Working for customers it could not have served a year ago: the company's deliverable capability just stepped up a class
The model's full reasoning — Q1 2018 call → NOWe need to determine if management conveys a step-change capability that is now being paid for and still early. Let's analyze the transcript. Key points: NovaSeq rollout, iSeq launch, consumables growth, microarray growth, oncology partnerships, etc. The question asks: "On this call, does management convey that the company CAN NOW ACTUALLY DO SOMETHING — produce, deliver, serve, handle, or perform at a scale, specification, quality, or complexity — that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, with the business it enables still early?" We need to find a specific capability step-change with before/after, paying work, and early stage. Look at NovaSeq: It was launched in 2017, so roughly a year ago it was available. But the transcript mentions NovaSeq consumables growth, S1 flow cell launched at AGBT in mid-February (2018). That's a new flow cell. But is that a capability step-change? It's a new product offering. However, the question asks about the company's capability to do something it couldn't do before. NovaSeq itself was a new instrument that enabled higher throughput. But the transcript says "NovaSeq consumables grew approximately 60% sequentially" and "S1 flow cell which we officially launched at AGBT in mid-February has received great customer feedback, and is expected to ramp throughout 2018." That suggests S1 is new and being adopted. But is that a step-change? It's a new flow cell for an existing platform. The capability to sequence with S1 might be new, but it's an incremental addition. Another candidate: iSeq. "we launched our iSeq platform in the first quarter and shipped units to customers for beta testing. During the beta test, we identified some opportunities to improve our corporate billing and shipping processes... We are in the process of validating these improvements and expect to scale shipments midyear." So iSeq is still in beta, not yet fully shipping. So that's not paying work yet. Microarray business: "microarray business had a spectacular start to 2018 with 48% growth to a record $152 million." But that's growth, not necessarily a new capability. The company already had microarray capability.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| TSSI | TSS, Inc. | Q4 2022 | 2023-04-03 | D |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| M | Macy's, Inc. | Q4 2022 | 2023-03-02 | D |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| CNXC | Concentrix Corporation | Q1 2022 | 2022-03-30 | B |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| NGVT | Ingevity Corporation | Q4 2021 | 2022-02-25 | B |
| VNDA | Vanda Pharmaceuticals Inc. | Q4 2021 | 2022-02-23 | F |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| SXC | SunCoke Energy, Inc. | Q3 2021 | 2021-11-01 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| CRS | Carpenter Technology Corporation | Q4 2021 | 2021-08-01 | A |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| AEHR | Aehr Test Systems | Q2 2017 | 2017-01-05 | F |
| NTCT | NetScout Systems, Inc. | Q2 2017 | 2016-10-27 | D |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
TGLS · Q2 2023 → YESThe question is about whether management conveys a new capability that they can now do something they couldn't do a year ago, that customers are paying for now, and it's still early. YES Management explicitly contrasts the new capability against the prior limitation: extra capacity now enables them to sell stand-alone architectural glass and aluminum framing products that were previously allocated to window production due to capacity constraints. This is a clear before/after step-change in the class of work they can accept and perform. Real customers are already paying for this new output: the transcript states they have a little bit more installation in stand-alone product sales the rest of the year, and they are now very well positioned to increasingly service large homebuilders’ customers as well as demand for the stand-alone aluminum and glass products, with the absorption of new capacity and ability to offer a wider range of solutions to customers described as positive overall.
TACT · Q4 2022 → YESThe question is: Does management convey that the company CAN NOW ACTUALLY DO SOMETHING that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, ...YES The transcript shows management describing a clear before/after step-change in casino and gaming printers: they could produce printers before, but now they have added a third line in Q3 and begun manufacturing on a fourth line in Q4, enabling them to meet demand and take market share that the prior competitor could not supply 12 months ago.
ZVIA · Q1 2022 → YESThe question is: Does management convey that the company CAN NOW ACTUALLY DO SOMETHING that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, ...YES Management describes the launch of single-serve 12-ounce cans as a first-time capability: “we began selling Zevia’s soda in single cans for the first time in a 12-ounce sleek format,” now “available cold in several grocery retailers” with “some of which is shipping now.